United States· US:0409-5092_3f749ee0-db14-4ed0-9056-d545a38bbe3b
TAZICEF
A medicinal product containing ceftazidime, registered in United States by Hospira, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CEFTAZIDIME
- Manufacturer
- Hospira, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc11040950921625 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5092-16) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5092-11)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ceftazidime in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALTECIMMedochemie Ltd., Limassol
- FinlandCeftazidim Bmm PharmaBMM Pharma AB
- BelgiumCeftazidim Hameln 1 gHameln Pharma
- SpainALFAGEM 1 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIONMedochemie Limited
- SwedenCeftazidim hameln 1 g Pulver till injektions-/infusionsvätska, lösningHameln Pharma gmbh
- PolandBiotumZakłady Farmaceutyczne POLPHARMA S.A.
- IrelandCeftazidime 1g Powder for solution for injection or infusionPinewood Laboratories Ltd
- NorwayCeftazidim MIPMIP Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Ceftazidim Aptapharma, Ceftazidim Hameln
- Belgium · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Bulgaria · Алфагем, Зидимцеф
- Cyprus · Alfagem, Cezid
- Czechia · Altecim, Ceftazidim Aptapharma
- Germany · Ceftazidim Dr. Eberth, Ceftazidim Hameln
- Denmark · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Estonia · Altecim, Ceftazidime Fresenius Kabi
- Spain · Alfagem, Ceftazidima Kabi
- Finland · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- France · Ceftazidime Arrow, Ceftazidime Enfants Et Nourrissons Panpharma
- United Kingdom (Northern Ireland) · Ceftazadime, Ceftazidime Cox Pharmaceutical
- Greece · Alfagem, Ceftaridem
- Croatia · Altecim, Cefaz
- Hungary · Ceftazidim Aptapharma, Ceftazidim Kabi
- Ireland · Ceftazidime Hameln, Ceftazidime Hikma Farmacêutica
- Iceland · Ceftazidim Fresenius Kabi, Ceftazidima Normon
- Italy · Ceftazidima Almus, Ceftazidima Astro-Pharma
- Lithuania · Biotum, Ceftazidime Kabi
- Luxembourg · Ceftazidim Fresenius Kabi, Glazidim
- Latvia · Ceftazidime Fresenius Kabi, Ceftazidime Mip
- Malta · Alfagem, Ceftazidima Fresenius
- Netherlands · Ceftazidim (Im/Iv) Mip, Ceftazidim (Iv) Mip
- Norway · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Poland · Biotum, Ceftazidim Aptapharma
- Portugal · Alfagem, Ceftazidima Accord
- Romania · Alfagem, Ceftamil
- Sweden · Ceftazidim Hameln, Fortum
- Slovenia · Ceftazidim Aptapharma, Ceftazidim Kabi
- Slovakia · Ceftazidim Ash, Ceftazidim Hameln
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f430d0b6-72b5-4dab-824f-addd0bdcc4bb GET /v1/drugs/f430d0b6-72b5-4dab-824f-addd0bdcc4bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 4
},
"productid": "0409-5092_3f749ee0-db14-4ed0-9056-d545a38bbe3b",
"productndc": "0409-5092",
"dosage_form": "INJECTION, POWDER, FOR SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "CEFTAZIDIME",
"proprietary_name": "TAZICEF",
"active_ingred_unit": "g/1",
"application_number": "ANDA064032",
"marketing_category": "ANDA",
"nonproprietary_name": "CEFTAZIDIME",
"start_marketing_date": "20060508",
"active_numerator_strength": "1"
}See everything about ceftazidime.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.